Ketamine clinical trials at UCLA

3 in progress, 2 open to eligible people

Showing trials for

  • Pragmatic Trial of Psilocybin Therapy in Palliative Care

    open to eligible people ages 18 years and up

    This multicenter, triple-blind, phase 2, randomized controlled trial will evaluate the efficacy and safety of psilocybin therapy compared to an active control in treating demoralization in adults near the end of life (≤2 years life expectancy).

    Los Angeles, California and other locations

  • Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

    open to eligible people ages 5-20

    The purpose of this research is to see if ketamine is effective and safe in treating children and young adults with sickle cell disease experiencing sickle cell related pain. In this study, we will compare the outcomes (such as pain scores) in persons who receive standard of care pain medicine (an opioid such as morphine) plus a low dose (amount) of ketamine to those who receive only standard of care pain medicine.

    Torrance, California

  • Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)

    Sorry, not currently recruiting here

    The goal of this clinical trial is to determine if treatment of patients with two doses of ketamine plus levetiracetam versus levetiracetam alone leads to more effective control of status epilepticus.

    Los Angeles, California and other locations

Our lead scientists for Ketamine research studies include .

Last updated: